Department of Neurosurgery, Shenyang First People's Hospital of Liaoning Province, PR China.
Department of Neurosurgery, Shengjing Hospital of China Medical University of Liaoning Province, PR China.
Clin Neurol Neurosurg. 2024 Apr;239:108192. doi: 10.1016/j.clineuro.2024.108192. Epub 2024 Feb 24.
This study compared the efficacies of robotic-assisted stereotactic hematoma drainage and suboccipital craniotomy (SC) in patients with spontaneous cerebellar hemorrhage (SCH).
This retrospective study included 138 non-comatose patients with SCH (Glasgow Coma Scale score [GCS] >8), divided into the SC and Robotic Stereotactic Assistance (ROSA) groups. The study recorded and analyzed complications and prognoses 90 days after ictus.
The inclusion criteria were met by 138 patients: 61 in the SC and 77 in the ROSA group, with no significant differences in sex, age, GCS score, hematoma volume, and the time from ictus to operation. The time of operation was greater in the SC group (287.53±87.57) than in the ROSA group (60.54±20.03). The evacuation rate (ER) was greater in the SC group (93.20±1.58) than in the ROSA group (89.13±2.75). The incidence of pneumonia and stress ulcers, as well as the length or costs of medical services, were lower in the ROSA group than in the SC group. Ninety days after ictus, the modified Rankin Scale (mRS), Glasgow Prognostic Scale (GOS), and Karnofsky Performance Scale (KPS) scores significantly differed between the groups. The rate of good prognosis in the ROSA group was significantly higher compared with that in the SC group. The incidence of balance disorders was lower in the ROSA group than in the SC group; no statistically significant difference was found in the incidence of dysarthria and swallowing disorders.
Robotic-assisted stereotactic hematoma drainage may be suitable for non-comatose and stable condition patients with SCH. This procedure improves prognosis 90 days after ictus, lowers the incidence of pneumonia and stress ulcers, and reduces the length and costs of medical services.
本研究比较了机器人辅助立体定向血肿引流术和枕下颅骨切开术(SC)治疗自发性小脑出血(SCH)的疗效。
本回顾性研究纳入了 138 例非昏迷 SCH 患者(格拉斯哥昏迷量表评分[GCS]>8),分为 SC 组和机器人立体定向辅助(ROSA)组。研究记录并分析了发病 90 天后的并发症和预后。
138 例患者符合纳入标准:SC 组 61 例,ROSA 组 77 例,两组患者的性别、年龄、GCS 评分、血肿量、发病至手术时间无显著差异。SC 组的手术时间(287.53±87.57)长于 ROSA 组(60.54±20.03)。SC 组的血肿清除率(ER)(93.20±1.58)高于 ROSA 组(89.13±2.75)。ROSA 组的肺炎和应激性溃疡发生率以及医疗服务的长度和费用均低于 SC 组。发病 90 天后,改良 Rankin 量表(mRS)、格拉斯哥预后量表(GOS)和卡诺夫斯基绩效量表(KPS)评分在两组间有显著差异。ROSA 组的预后良好率明显高于 SC 组。ROSA 组的平衡障碍发生率低于 SC 组,言语障碍和吞咽障碍的发生率两组间无统计学差异。
机器人辅助立体定向血肿引流术适用于非昏迷和稳定的 SCH 患者。该术式可改善发病 90 天后的预后,降低肺炎和应激性溃疡的发生率,缩短医疗服务的长度并降低费用。